I am Laura Llacuna

Biologist, PhD in Biomedicine, Health Coach and Psiconeuroimmunologist.

I am Laura Llacuna

Biologist, PhD in Biomedicine, Health Coach and Psiconeuroimmunologist.

I am a mother and an entrepreneur and I am passionate about studying life, discovering the world, healthy food, nature and dance.

I work in the field of Integrative Health, helping patients who come to my consult looking for solutions to their health problems in order to live fully. I think it is necessary to understand the reason and the origin of these problems in order to be able to heal them from the root cause and that is why I am always doing research and studying to find answers.

Me myself, like many of my patients, had to face health problems that affected my quality of life and reduced my energy to be able to do what I liked, so I have always been very interested in knowing how the body works and I am clear that absolutely everything affects us. This led me to study Biology, I continued my studies obtaining a PhD in Biomedicine and dedicated more than ten years to research in different scientific labs.


I am a scientist and I like to understand the reason of things, the mechanisms, the biochemistry of the body and I need to know the scientific evidence.

During my postdoctoral stage at Mount Sinai Hospital in New York, where I did research in the field of cancer, I realized that I wanted to go to another level. I loved my work in the laboratory, but there were always the results on the shelves or in scientific articles that I didn’t know if they were really helping on a personal level. I felt the need to transmit my knowledge and studies in another way, connecting directly with patients and explaining the importance and the influence that personalized nutrition and lifestyle habits have on how we feel, so I got trained at the Institute of Integrative Nutrition (IIN) in New York, and later decided to do a postgraduate degree in Psychoneuroimmunology.

My time in New York was for me so important, a period of expansion and discovery, I learned a lot and I have that time deep in my heart. I trained with the best Health Coaches, I entered the field of Ayurveda, I had to overcome many obstacles and that at the same time, it opened doors for me and gave me a broader and multidisciplinary vision of life and health.

As a researcher, integrative therapist and psychoneuroimmunologist, my mission is  to help people who, like me, want to transform their health and improve their lives.

Follow your intuition and don’t give up what makes you feel alive!

Here you can check with more detail
my Curriculum Vitae:

My studies:

My trajectory:

  • Liscio P, Carotti A, Asciutti S, Karlberg T, Bellocchi D, Llacuna L, Macchiarulo A, Aaronson SA, Schüler H, Pellicciari R, Camaioni E. Design, Synthesis, Crystallographic Studies, and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors. J Med Chem. 2014 Mar 27;57(6):2807-12.
  • Farrés J, Llacuna L, Martin-Caballero J, Martínez C, Lozano JJ, Ampurdanés C, López-Contreras AJ, Florensa L, Navarro J,Ottina E, Dantzer F, Schreiber V, Villunger A, Fernández-Capetillo O, Yélamos J. PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors. Cell Death Differ. 2015 Jul;22(7):1144-57.
  • Florian J. Bock , Gerhard Krumschnabel , Claudia Manzl , Lukas Peintner, Natascha Hermann-Kleiter, Laura Llacuna, Jose Yelamos and Andreas Villunger. Loss of PIDD limits NF-κB activation and cytokine production but not cell survival or transformation after DNA damage. Cell Death Differ. 2013 Apr;20(4):546-57. 
  • Farrés J, Martín-Caballero J, Martínez C, Lozano JJ, Llacuna L, Ampurdanés C, Ruiz-Herguido C, Dantzer F, Schreiber V, Villunger A, Bigas A, Yélamos J. Parp-2 is required to maintain hematopoiesis following sublethal γ-irradiation in mice. Blood. 2013 Jul 4;122(1):44-54.
  • Llacuna L, Mach N. Papel de los antioxidants en la prevención del cáncer. Rev Esp Nutr Hum Diet. 2012; 16 (1): 16-24.
  • Yelamos J, Farrés J, Llacuna L, Ampurdanés C, Martín-Caballero J. PARP-1 and PARP-2: New players in tumor development. Am J Cancer Res 2011; 1(3): 328-346.
  • Angulo S, Morales A, Danese S, Llacuna L, Masamunt MC, Pultz N, Cifone MG, De Simone C, Delgado S, Vila J, Panés J, Donskey C, Fernández-Checa JC, Fiocchi C, Sans M. Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase. PLoS One. 2011 Mar 9;6(3):e16953.
  • Llacuna L, Fernández A, Von Monfort C, Matías N, Martínez L, Caballero F, Rimola A, Elena M, Morales A, Fernández-Checa JC, Carmen García-Ruiz C. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury. J Hepatol. 2011 May;54(5):1002-10.
  • Llacuna L, Bárcena C, Bellido-Martín L, Fernández L, Stefanovic M, Marí M, García-Ruiz C, Fernández-Checa JC, García de Frutos P, Morales A. Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury. Hepatology. 2010 Oct;52(4):1371-9.
  • Lluis JM, Llacuna L, von Montfort C, Bárcena C, Enrich C, Morales A, Fernandez-Checa JC. GD3 synthase overexpression sensitizes hepatocarcinoma cells to hypoxia and reduces tumor growth by suppressing the cSrc/NF-kappaB survival pathway. PLoS One. 2009 Nov 26;4(11):e8059.
  • Fernández A, Llacuna L, Fernández-Checa JC, Anna Colell. Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity. Journal of Neuroscience, 2009 May 20;29(20):6394-405.
  • Llacuna L, Marí M, Lluis JM, García-Ruiz C, Fernández-Checa JC, Morales A. Reactive oxygen species mediate liver injury through parenchymal Nf-κB inactivation in prolonged ischemia/reperfusion. American Journal Pathology, 2009 May;174(5):1776-85.
  • Montero J, Morales A, Llacuna L, Lluis JM, Terrones O, Basañez G, Antonsson B, Prieto J, Garcia-Ruiz C, Colell A, Fernández-Checa JC. Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma. Cancer Res. 2008 Jul 1;68(13):5246-56.
  • Morales A, Paris R, Villanueva A, Llacuna L, Garcia-Ruiz C, Fernández-Checa JC. Pharmacological inhibition of small interfering RNA targetic acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo. Oncogene. 2007 Feb 8;26(6):905-16.
  • Llacuna L, Mari M, Garcia-Ruiz C, Fernández-Checa JC, Morales A. Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. Hepatology. 2006 Sep; 44(3): 561-72.
  • Llacuna L, Bullich C, Verdaguer X, Millan F. Psiconeuroinmunoendocrinología enfoque de la salud y la enfermedad. SENMO. 2019